Fahim Ebrahimi

Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

Guntram Schernthaner, Naim Shehadeh, Anna Bazarova et al. · Cardiovascular Diabetology · 2020 · 160 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial

Fahim Ebrahimi, Stavros Giaglis, Sinuhe Hahn et al. · European Respiratory Journal · 2018 · 116 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis

Julie Refardt, Cornelia Imber, Clara Odilia Sailer et al. · Journal of the American Society of Nephrology · 2020 · 112 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

External validation of the GREAT score to predict relapse risk in Graves’ disease: results from a multicenter, retrospective study with 741 patients

Tristan Struja, Marina Kaeslin, Fabienne Boesiger et al. · European Journal of Endocrinology · 2017 · 69 citations

Pharmacy, Endocrinology, Pharmacotherapy +13

Association of the Swiss Diagnosis-Related Group Reimbursement System With Length of Stay, Mortality, and Readmission Rates in Hospitalized Adult Patients

Alexander Kutz, Lara Gut, Fahim Ebrahimi et al. · JAMA Network Open · 2019 · 69 citations · Full text

Public Affairs, Health Policy, Health Services Administration +17